Evidence map›Paper›PMID 10662844›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2000

alpha-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression.

C Fekete, G Légrádi, E Mihály, Q H Huang, J B Tatro, W M Rand, C H Emerson, R M Lechan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 309 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Cardamom (International journal of molecular sciences · 2023
    Article
  11. Review
  12. Review
  13. Leptin Receptor Compound Heterozygosity in Humans and Animal Models.International journal of molecular sciences · 2021
    Review
  14. Neuroendocrine control of appetite and metabolism.Experimental & molecular medicine · 2021
    Review
  15. Review
  16. Article
  17. The Role of the Thyroid Axis in Fish.Frontiers in endocrinology · 2020
    Review
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

C FeketeTupper Research Institute, Department of Medicine, Division of Endocrinology, New England Medical Center, Boston, Massachusetts 02111, USA.
G Légrádi
E Mihály
Q H Huang
J B Tatro
W M Rand
C H Emerson
R M Lechan
Tufts Medical Center · USHUN-REN Institute of Experimental Medicine · HUTufts University · USUniversity of Massachusetts Chan Medical School · US

Funding

TRH REGULATION/BIOSYNTHESIS IN PARAVENTRICULAR NUCLEUSR01DK037021 · NIDDK · TUFTS MEDICAL CENTER · PI LECHAN, RONALD MICHAEL · 1986 to 2010
$3.9M
TRH REGULATION/BIOSYNTHESIS AND PARAVENTRICULAR NUCLEUSR56DK037021 · NIDDK · TUFTS MEDICAL CENTER · PI LECHAN, RONALD MICHAEL · 2007 to 2007
$201k
NIDDK NIH HHS DK-37021NIDDK NIH HHS R01 DK037021NIDDK NIH HHS R56 DK037021
6 · The paper itself

Abstract

The hypothalamic arcuate nucleus has an essential role in mediating the homeostatic responses of the thyroid axis to fasting by altering the sensitivity of prothyrotropin-releasing hormone (pro-TRH) gene expression in the paraventricular nucleus (PVN) to feedback regulation by thyroid hormone. Because agouti-related protein (AGRP), a leptin-regulated, arcuate nucleus-derived peptide with alpha-MSH antagonist activity, is contained in axon terminals that terminate on TRH neurons in the PVN, we raised the possibility that alpha-MSH may also participate in the mechanism by which leptin influences pro-TRH gene expression. By double-labeling immunocytochemistry, alpha-MSH-IR axon varicosities were juxtaposed to approximately 70% of pro-TRH neurons in the anterior and periventricular parvocellular subdivisions of the PVN and to 34% of pro-TRH neurons in the medial parvocellular subdivision, establishing synaptic contacts both on the cell soma and dendrites. All pro-TRH neurons receiving contacts by alpha-MSH-containing fibers also were innervated by axons containing AGRP. The intracerebroventricular infusion of 300 ng of alpha-MSH every 6 hr for 3 d prevented fasting-induced suppression of pro-TRH in the PVN but had no effect on AGRP mRNA in the arcuate nucleus. alpha-MSH also increased circulating levels of free thyroxine (T4) 2.5-fold over the levels in fasted controls, but free T4 did not reach the levels in fed controls. These data suggest that alpha-MSH has an important role in the activation of pro-TRH gene expression in hypophysiotropic neurons via either a mono- and/or multisynaptic pathway to the PVN, but factors in addition to alpha-MSH also contribute to the mechanism by which leptin administration restores thyroid hormone levels to normal in fasted animals.

Indexed as

alpha-MSHAnimalsBody WeightFastingGene Expression RegulationImmunohistochemistryIn Situ HybridizationMaleMicroscopy, ImmunoelectronNerve EndingsNeuronsParaventricular Hypothalamic NucleusProtein PrecursorsPyrrolidonecarboxylic AcidRatsRats, Sprague-Dawleyalpha-MSHProtein Precursorspro-thyrotropin releasing hormonePyrrolidonecarboxylic AcidThyrotropinThyrotropin-Releasing HormoneThyroxine

Identifiers

PMID10662844
PMCPMC6772359
OpenAlexW2120635941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.